الرشاقة الاستراتيجية و أثرها في تعزيز الميزة التنافسية : دراسة ميدانية على شركات صناعة الأدوية الفلسطينية

Abstract EN

The Study aimed to explore the impact of strategic agility in enhancing the competitive advantage of the Palestinian Pharmaceutical Industrial Companies.

To achieve the objective of the Study, the Descriptive Analytical Approach was adopted.

The Study population consists of (166) employees in supervisory positions at the Palestinian Pharmaceutical Industrial Companies.

A comprehensive Census method was used to distribute the questionnaire to the study population.

(145) questionnaires were returned with a recovery rate of (87.3%), and the SPSS program was used for data entry and analyzing and hypothesis testing.

The most important findings of this Study were: The level of availability of strategic agility involved a high degree of approval with a relative weight of (80.2%), and the level of competitive advantage also had a high degree of approval with the relative weight of (75.8%).

There is a statistically significant positive relationship between the practice of strategic agility and the enhancement of the competitive advantage, and the results also showed that there is a statistically significant impact of the strategic agility's dimensions on the enhancement of the competitive advantage, which has explained (58.8%) of the variance in the competitive advantage, whereas the dimension of core capabilities had no effect.

The most important recommendations of the Study: Adopting the approach to strategic agility and disseminating its philosophy and principles and enhancing its practice at all levels as an essential factor having great importance in enhancing the competitive advantage through improving the products' quality, reducing costs, expediting response and delivery, and reducing the squandering of resources